Evaluation of the Effect of SGLT-2 Inhibitors on Cardiac Remodeling in Post Myocardial Infarction Patients

NCT05335629 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction
Diabetes Mellitus, Type 2
Myocardial Remodeling, Ventricular

Interventions

DRUG: Dapagliflozin 10Mg Tab

Sponsor

Ain Shams University